---
title: "Avalo Therapeutics GAAP EPS of -$5.84 beats by $0.47, revenue of $0.06M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280149359.md"
description: "Avalo Therapeutics GAAP EPS of -$5.84 beats by $0.47, revenue of $0.06M"
datetime: "2026-03-23T11:12:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280149359.md)
  - [en](https://longbridge.com/en/news/280149359.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280149359.md)
---

# Avalo Therapeutics GAAP EPS of -$5.84 beats by $0.47, revenue of $0.06M


### Related Stocks

- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BMED.US](https://longbridge.com/en/quote/BMED.US.md)
- [AVTX.US](https://longbridge.com/en/quote/AVTX.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [TMED.US](https://longbridge.com/en/quote/TMED.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [These Analysts Revise Their Forecasts On Avalo Therapeutics After Q1 Results](https://longbridge.com/en/news/286424446.md)
- [Avalo Therapeutics Urges Investors to Heed Form 10-Q Risk Factors Amid Ongoing Uncertainty](https://longbridge.com/en/news/286366040.md)
- [Avalo Therapeutics Q1 net loss widens on increased R&D spend](https://longbridge.com/en/news/286249018.md)
- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)